Flipped-Discharge Education for PTCD-Managed Malignant Obstructive Jaundice
Impact of a Flipped-Discharge Education Model on Therapeutic Outcomes, Self-Care Capacity, and Quality of Life in PTCD-Managed Malignant Obstructive Jaundice: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
This single-center randomized controlled trial evaluated whether a structured flipped-discharge education model improves discharge readiness and short-term outcomes compared with routine discharge education in adults with malignant obstructive jaundice managed with percutaneous transhepatic cholangiodrainage (PTCD). Participants were randomized 1:1 to flipped-discharge education or routine education and followed for approximately 28 days after discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 29, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedApril 13, 2026
April 1, 2026
6 months
March 29, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readiness for hospital discharge as assessed by the Readiness for Hospital Discharge Scale (RHDS)-Adult Form
The Readiness for Hospital Discharge Scale (RHDS)-Adult Form measures patient readiness to return home following acute care hospitalization. According to the scale developer, the RHDS score is calculated by adding the item scores and dividing by the number of items to obtain a mean item score. Possible scores range from 0 to 10, with higher scores indicating greater readiness for hospital discharge and therefore a better outcome.
Approximately 28 days after discharge
Secondary Outcomes (3)
Family functioning as assessed by the Family APGAR
Approximately 28 days after discharge
Self-care agency as assessed by the Exercise of Self-Care Agency Scale (ESCA)
Approximately 28 days after discharge
Physical health quality of life as assessed by the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF)
Approximately 28 days after discharge
Study Arms (2)
Flipped-Discharge Education
EXPERIMENTALParticipants received a structured flipped-discharge education program, including staged pre-discharge training, individualized nursing planning, and weekly telehealth follow-up during the first 4 weeks after discharge.
Routine Education
ACTIVE COMPARATORParticipants received routine discharge education, including standard written and verbal PTCD catheter care instructions and post-discharge precautions.
Interventions
Standard discharge education delivered by healthcare providers, including self-guided review of health manuals, verbal explanation of PTCD catheter care, and a checklist of post-discharge precautions.
Structured education delivered by a multidisciplinary team, including PTCD catheter-care training, individualized discharge planning, and weekly telehealth follow-up during the first 4 weeks after discharge.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Diagnosed with malignant obstructive jaundice
- Undergoing percutaneous transhepatic cholangiodrainage (PTCD)
- Clear indication for PTCD, such as unresectable biliary obstruction
- Preserved consciousness and ability to communicate
- Provided written informed consent
You may not qualify if:
- Psychiatric disorders
- Active severe infection
- Hematologic disease
- Language barriers
- Anticipated loss to follow-up
- Disease progression, death during the study period, or voluntary withdrawal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foshan First People's Hospital
Foshan, Guangdong, 528000, China
Study Officials
- PRINCIPAL INVESTIGATOR
Xia Xiang, BS
First People's Hospital of Foshan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the educational nature of the intervention, participants and educators were not blinded. Outcome assessors and data analysts were blinded to group assignment.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nurse
Study Record Dates
First Submitted
March 29, 2026
First Posted
April 13, 2026
Study Start
December 1, 2023
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
April 13, 2026
Record last verified: 2026-04